Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Malaise,	O
generalized	O
weakness	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
PICC	O
Line	O
Placement	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
an	O
___	O
year-old	O
man	O
with	O
PMH	O
significant	O
for	O
HTN,	O
HLD,	O
polycystic	O
kidney	O
disease,	O
CKD	O
(baseline	O
Cr	O
1.2-1.3),	O
and	O
aortic	O
dissection	O
s/p	O
repair	O
who	O
presents	O
with	O
malaise.	O
The	O
patient	O
reports	O
that	O
for	O
the	O
last	O
___	O
days	O
he	O
has	O
had	O
generalized	O
weakness.	O
In	O
this	O
setting,	O
has	O
subjectively	O
felt	O
"warm"	O
and	O
"jittery."	O
He	O
denies	O
chest	O
pain,	O
SOB,	O
cough,	O
abdominal	O
pain,	O
diarrhea.	O
He	O
has	O
chronic	O
constipation,	B-Constipation
but	O
reports	O
that	O
since	O
starting	O
Miralax,	O
he	O
has	O
had	O
regular	O
bowel	O
movements,	O
most	O
recently	O
___	O
morning.	O
In	O
___	O
ED:	O
-	O
Initial	O
VS	O
99.0	O
85	O
131/63	O
18	O
94%	O
RA	O
-	O
Labs	O
notable	O
for	O
Chem-7	O
with	O
BUN/Cr	O
41/1.6	O
(baseline	O
Cr	O
1.2-1.3)	O
otherwise	O
wnl,	O
CBC	O
with	O
WBC	O
10.9	O
H/H	O
10.2/30.8,	O
Trop	O
0.03->0.03,	O
lactate	O
1.1.	O
UA	O
negative.	O
-	O
CXR	O
with	O
no	O
acute	O
cardiopulmonary	O
process.	O
CT	O
A/P	O
w/o	O
con	O
notable	O
for	O
"Large	O
7.2	O
cm	O
stool	O
ball	O
in	O
the	O
distal	O
colon	O
with	O
mild	O
adjacent	O
wall	O
thickening,	O
which	O
could	O
reflect	O
early	O
stercoral	O
colitis"	O
as	O
well	O
as	O
incidental	O
finding	O
of	O
"more	O
focal	O
consolidation	O
in	O
the	O
posterior	O
left	O
lower	O
lobe."	O
-	O
___	O
EKG	O
with	O
SR@85,	O
NANI,	O
new	O
incomplete	O
LBBB,	O
otherwise	O
no	O
ST-T	O
changes	O
to	O
suggest	O
ischemia.	O
___	O
EKG	O
with	O
SR@74,	O
borderline	O
QTc	O
of	O
443,	O
T-wave	O
faltting	O
in	O
III	O
and	O
V2-V3	O
but	O
no	O
acute	O
ischemic	O
changes.	O
-	O
Upon	O
arrival	O
to	O
the	O
floor,	O
VS	O
97.9	O
126/52	O
80	O
18	O
94%RA.	O
The	O
patient	O
reports	O
feeling	O
tired	O
but	O
is	O
otherwise	O
without	O
specific	O
complaints	O
including	O
fever,	O
chest	O
pain,	O
SOB,	O
abdominal	O
pain.	O
ROS:	O
(+)	O
Per	O
HPI	O
(-)	O
Denies	O
fever,	O
recent	O
weight	B-Weight_loss
loss	B-Weight_loss
or	O
gain.	O
Denies	O
headache,	O
sinus	O
tenderness,	O
rhinorrhea	O
or	O
congestion.	O
Denies	O
cough,	O
shortness	O
of	O
breath.	O
Denies	O
chest	O
pain	O
or	O
tightness,	O
palpitations.	O
Denies	O
nausea,	O
vomiting,	O
diarrhea,	O
constipation	B-Constipation
or	O
abdominal	O
pain.	O
No	O
recent	O
change	O
in	O
bowel	O
or	O
bladder	O
habits.	O
No	O
dysuria.	O
Denies	O
arthralgias	O
or	O
myalgias.	O
Past	O
Medical	O
History:	O
Hypertension	O
Hyperlipidemia	O
Aortic	O
dissection	O
Type	O
A	O
s/p	O
aortic	O
hemi-arch	O
replacemnt	O
and	O
aortic	O
valve	O
resuspension	O
___	O
Polycystic	O
kidney	O
disease	O
with	O
CKD	O
(baseline	O
Cr	O
1.2-1.3)	O
Osteopenia	O
Prostate	O
cancer	O
s/p	O
radical	O
prostatectomy	O
___	O
c/b	O
urinary	O
incontinence	O
BCC	O
Ulnar	O
neuropathy	O
of	O
left	O
arm	O
post	O
aortic	O
dissection	O
repair	O
Old	O
left	O
kidney	O
surgey	O
via	O
left	O
flank	O
incision	O
many	O
years	O
ago	O
RFA	O
of	O
kidney	O
lesoin	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Father-chf,	O
MI	O
Brother-chf	O
at	O
age	O
___	O
Sister-diabetes	O
(type	O
2)	O
Sister-healthy	O
Physical	O
___:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
=========================	O
Vital	O
Signs:	O
97.9	O
126/52	O
80	O
18	O
94%RA	O
General:	O
Alert,	O
oriented,	O
no	O
acute	O
distress	O
HEENT:	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear,	O
EOMI,	O
PERRL,	O
neck	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
III/VI	O
systolic	O
murmur,	O
II/IV	O
diastolic	O
murmur,	O
no	O
rubs/gallops	O
Lungs:	O
Crackles	O
in	O
bilateral	O
bases	O
otherwise	O
clear	O
to	O
auscultation	O
bilaterally	O
Abdomen:	O
Distended	O
but	O
soft,	O
non-tender,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
or	O
guarding	O
GU:	O
No	O
foley	O
Ext:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
Neuro:	O
CNII-XII	O
intact,	O
___	O
strength	O
upper/lower	O
extremities,	O
grossly	O
normal	O
sensation,	O
2+	O
reflexes	O
bilaterally,	O
gait	O
deferred.	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
Vitals:	O
T=97.5	O
BP=158/72	O
HR=72	O
RR=18	O
SpO2=95%	O
on	O
RA	O
General:	O
Alert,	O
in	O
no	O
acute	O
distress.	O
HEENT:	O
Anicteric	O
sclera,	O
pale	O
conjunctiva,	O
MMM.	O
Neck:	O
Supple,	O
No	O
JVD	O
CV:	O
RRR,	O
normal	O
S1/S2,	O
III/VI	O
systolic	O
and	O
diastolic	O
murmur	O
Lungs:	O
Decreased	O
air	O
entry	O
at	O
the	O
bases	O
bilaterally.	O
Minimal	O
basilar	O
crackles.	O
No	O
wheezes	O
or	O
ronchi	O
Abdomen:	O
Soft,	O
significantly	O
distended,	O
non-tender,	O
no	O
rebound	O
or	O
guarding.	O
+BS	O
Back:	O
No	O
spinous	O
tenderness.	O
Ext:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
cyanosis,	O
2+	O
BLE	O
edema.	O
Swollen	O
hands	O
bilaterally.	O
Skin:	O
No	O
petechiae	O
or	O
splinter	O
hemorrhages	O
Neuro:	O
AOx3.	B-Delirium
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
===============	O
___	O
05:37PM	O
WBC-10.9*#	O
RBC-3.00*	O
HGB-10.2*	O
HCT-30.8*	O
MCV-103*	O
MCH-34.0*	O
MCHC-33.1	O
RDW-13.5	O
RDWSD-51.6*	O
___	O
05:37PM	O
NEUTS-89*	O
BANDS-2	O
LYMPHS-5*	O
MONOS-4*	O
EOS-0	O
BASOS-0	O
___	O
MYELOS-0	O
AbsNeut-9.92*	O
AbsLymp-0.55*	O
AbsMono-0.44	O
AbsEos-0.00*	O
AbsBaso-0.00*	O
___	O
05:37PM	O
HYPOCHROM-NORMAL	O
ANISOCYT-NORMAL	O
POIKILOCY-OCCASIONAL	O
MACROCYT-1+	O
MICROCYT-NORMAL	O
POLYCHROM-NORMAL	O
OVALOCYT-OCCASIONAL	O
___	O
05:37PM	O
PLT	O
SMR-LOW	O
PLT	O
COUNT-110*	O
___	O
05:37PM	O
___	O
PTT-28.2	O
___	O
___	O
05:37PM	O
ALBUMIN-4.1	O
___	O
05:37PM	O
CK-MB-2	O
___	O
05:37PM	O
cTropnT-0.03*	O
___	O
05:37PM	O
ALT(SGPT)-21	O
AST(SGOT)-28	O
CK(CPK)-177	O
ALK	O
PHOS-86	O
TOT	O
BILI-0.5	O
___	O
05:37PM	O
GLUCOSE-123*	O
UREA	O
N-41*	O
CREAT-1.6*	O
SODIUM-136	O
POTASSIUM-4.4	O
CHLORIDE-98	O
TOTAL	O
CO2-24	O
ANION	O
GAP-18	O
___	O
06:30PM	O
URINE	O
MUCOUS-RARE	O
___	O
06:30PM	O
URINE	O
HYALINE-3*	O
___	O
06:30PM	O
URINE	O
RBC-1	O
WBC-1	O
BACTERIA-NONE	O
YEAST-NONE	O
EPI-0	O
___	O
06:30PM	O
URINE	O
COLOR-Yellow	O
APPEAR-Clear	O
SP	O
___	O
___	O
12:33AM	O
LACTATE-1.1	O
___	O
06:50AM	O
TSH-1.8	O
___	O
06:50AM	O
VIT	O
___	O
FOLATE->20	O
DISCHARGE	O
LABS:	O
===============	O
___	O
06:11AM	O
BLOOD	O
WBC-10.3*	O
RBC-2.87*	O
Hgb-9.0*	O
Hct-27.2*	O
MCV-95	O
MCH-31.4	O
MCHC-33.1	O
RDW-17.1*	O
RDWSD-60.2*	O
Plt	O
___	O
___	O
06:11AM	O
BLOOD	O
Plt	O
___	O
___	O
06:11AM	O
BLOOD	O
Glucose-99	O
UreaN-102*	O
Creat-2.5*	O
Na-135	O
K-4.8	O
Cl-103	O
HCO3-19*	O
AnGap-18	O
___	O
06:11AM	O
BLOOD	O
Calcium-8.6	O
Phos-5.3*	O
Mg-2.5	O
___	O
06:11AM	O
BLOOD	O
Vanco-20.0	O
OTHER	O
NOTABLE	O
LABS:	O
===================	O
___	O
03:46AM	O
BLOOD	O
C3-55*	O
C4-33	O
___	O
12:04PM	O
BLOOD	O
PEP-NO	O
SPECIFI	O
___	O
06:50AM	O
BLOOD	O
___	O
Folate->20	O
___	O
07:35AM	O
BLOOD	O
%HbA1c-5.3	O
eAG-105	O
___	O
06:50AM	O
BLOOD	O
TSH-1.8	O
___	O
09:43AM	O
URINE	O
CastHy-5*	O
___	O
02:33PM	O
URINE	O
Eos-NEGATIVE	O
___	O
12:04PM	O
URINE	O
U-PEP-NEGATIVE	O
F	O
MICROBIOLOGY:	O
=============	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
___	O
AUREUS	O
COAG	O
+.	O
FINAL	O
SENSITIVITIES.	O
Consultations	O
with	O
ID	O
are	O
recommended	O
for	O
all	O
blood	O
cultures	O
positive	O
for	O
Staphylococcus	O
aureus,	O
yeast	O
or	O
other	O
fungi.	O
Oxacillin	O
RESISTANT	O
Staphylococci	O
MUST	O
be	O
reported	O
as	O
also	O
RESISTANT	O
to	O
other	O
penicillins,	O
cephalosporins,	O
carbacephems,	O
carbapenems,	O
and	O
beta-lactamase	O
inhibitor	O
combinations.	O
Rifampin	O
should	O
not	O
be	O
used	O
alone	O
for	O
therapy.	O
This	O
isolate	O
is	O
presumed	O
to	O
be	O
resistant	O
to	O
clindamycin	O
based	O
on	O
the	O
detection	O
of	O
inducible	O
resistance	O
.	O
TETRACYCLINE	O
Susceptibility	O
testing	O
requested	O
by	O
___.	O
___	O
___	O
(___).	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
__________________________________________________	O
___	O
AUREUS	O
COAG	O
+	O
|	O
CLINDAMYCIN-----------	O
R	O
ERYTHROMYCIN----------	O
=>8	O
R	O
GENTAMICIN------------	O
<=0.5	O
S	O
LEVOFLOXACIN----------	O
=>8	O
R	O
OXACILLIN-------------	O
=>4	O
R	O
RIFAMPIN--------------	O
<=0.5	O
S	O
TETRACYCLINE----------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
<=0.5	O
S	O
VANCOMYCIN------------	O
<=0.5	O
S	O
Anaerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
POSITIVE	O
COCCI	O
IN	O
CLUSTERS.	O
Reported	O
to	O
and	O
read	O
back	O
by	O
___	O
ON	O
___,	O
12:42PM.	O
Aerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
POSITIVE	O
COCCI	O
IN	O
CLUSTERS.	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
___	O
AUREUS	O
COAG	O
+.	O
SENSITIVITIES	O
PERFORMED	O
ON	O
CULTURE	O
#	O
___	O
___.	O
Consultations	O
with	O
ID	O
are	O
recommended	O
for	O
all	O
blood	O
cultures	O
positive	O
for	O
Staphylococcus	O
aureus,	O
yeast	O
or	O
other	O
fungi.	O
Aerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
POSITIVE	O
COCCI	O
IN	O
CLUSTERS.	O
Reported	O
to	O
and	O
read	O
back	O
by	O
___	O
___	O
02:00.	O
Anaerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
POSITIVE	O
COCCI	O
IN	O
CLUSTERS.	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
C.	O
difficile	O
DNA	O
amplification	O
assay	O
(Final	O
___:	O
Negative	O
for	O
toxigenic	O
C.	O
difficile	O
by	O
the	O
Illumigene	O
DNA	O
amplification	O
assay.	O
IMAGING:	O
=========	O
CXR	O
(___)	O
No	O
acute	O
cardiopulmonary	O
process.	O
CT	O
ABD/PELVIS	O
w/o	O
CONTRAST	O
(___)	O
1.	O
Large	O
rounded	O
stool	O
in	O
the	O
distal	O
rectum	O
with	O
mild	O
adjacent	O
wallthickening,	O
which	O
could	O
reflect	O
early	O
stercoral	O
colitis.	O
2.	O
Incidental	O
note	O
of	O
a	O
more	O
focal	O
consolidation	O
in	O
the	O
posterior	O
left	O
lowerlobe,	O
for	O
which	O
developing	O
infection	O
is	O
possible	O
given	O
the	O
patient's	O
clinicalhistory.	O
Bibasilar	O
atelectasis	O
is	O
dense.	O
3.	O
Persistent	O
1.2	O
cm	O
non-obstructing	O
right	O
lower	O
renal	O
stone.	O
4.	O
Extensive	O
polycystic	O
kidney	O
disease	O
limiting	O
evaluation	O
forintra-abdominal	O
fat	O
stranding.	O
5.	O
The	O
known	O
complex	O
thoraco-abdominal	O
aorta,	O
SMA,	O
and	O
right	O
iliac	O
arterydissection	O
is	O
not	O
well	O
evaluated	O
in	O
the	O
absence	O
of	O
IV	O
contrast.	O
TRANSTHORACIC	O
ECHO	O
(___)	O
The	O
left	O
atrium	O
is	O
moderately	O
dilated.	O
Left	O
ventricular	O
wall	O
thickness,	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
are	O
normal	O
(LVEF	O
>55%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
Moderate	O
(2+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Mild	O
(1+)	O
mitral	O
regurgitation	O
is	O
seen.	O
Moderate	O
[2+]	O
tricuspid	O
regurgitation	O
is	O
seen.	O
There	O
is	O
borderline	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
PELVIS	O
AP	O
(___)	O
Penile	O
implant	O
in-situ	O
with	O
apparent	O
coil	O
like	O
components	O
distally.	O
There	O
are	O
surgical	O
clips	O
in	O
the	O
pelvis.	O
There	O
are	O
mild	O
degenerative	O
changes	O
at	O
the	O
right	O
hip.	O
No	O
acute	O
fracture	O
or	O
concerning	O
bone	O
lesion.	O
CTA	O
TORSO	O
(___)	O
1.	O
Multiple	O
small	O
fluid	O
collections	O
measuring	O
up	O
to	O
1.5	O
x	O
1.0	O
cm	O
and	O
inflammatory	O
changes	O
are	O
adjacent	O
to	O
the	O
thoracic	O
ascending	O
aorta	O
and	O
endovascular	O
graft	O
and	O
raise	O
concern	O
for	O
graft	O
infection	O
with	O
small	O
abscesses.	O
2.	O
No	O
evidence	O
of	O
psoas	O
abscess.	O
3.	O
The	O
known	O
complex	O
thoracoabdominal	O
aorta,	O
SMA,	O
and	O
right	O
iliac	O
artery	O
dissection	O
is	O
stable	O
from	O
CTA	O
torso	O
___.	O
4.	O
Polycystic	O
kidney	O
disease	O
and	O
nonobstructing	O
renal	O
stones	O
are	O
stable	O
TRANSTHORACIC	O
ECHO	O
(___)	O
Left	O
ventricular	O
wall	O
thickness,	O
cavity	O
size,	O
and	O
global	O
systolic	O
function	O
are	O
normal	O
(LVEF>55%).	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
No	O
masses	O
or	O
vegetations	O
are	O
seen	O
on	O
the	O
aortic	O
valve.	O
Moderate	O
(2+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
No	O
mass	O
or	O
vegetation	O
is	O
seen	O
on	O
the	O
mitral	O
valve.	O
Mild	O
(1+)	O
mitral	O
regurgitation	O
is	O
seen.	O
Significant	O
pulmonic	O
regurgitation	O
is	O
seen.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
is	O
an	O
___	O
man	O
with	O
h/o	O
HTN,	O
HLD,	O
polycystic	O
kidney	O
disease,	O
CKD	O
(baseline	O
Cr	O
1.2-1.3),	O
and	O
aortic	O
dissection	O
s/p	O
repair	O
who	O
presented	O
with	O
fatigue	O
and	O
malaise	O
and	O
was	O
found	O
to	O
have	O
MRSA	O
septicemia	O
likely	O
due	O
to	O
an	O
infected	O
ascending	O
aortic	O
graft	O
vs.	O
endocarditis.	O
His	O
hospital	O
course	O
was	O
complicated	O
by	O
an	O
acute	O
on	O
chronic	O
kidney	O
injury.	O
#	O
MRSA	O
Septicemia:	O
Patient	O
admitted	O
for	O
fatigue	O
and	O
malaise	O
without	O
any	O
signs	O
of	O
sepsis.	O
On	O
admission,	O
the	O
patient's	O
vitals	O
were	O
stable.	O
His	O
labs	O
were	O
remarkable	O
for	O
BUN/Cr	O
41/1.6	O
slightly	O
elevated	O
WBC	O
10.9,	O
and	O
H/H	O
10.2/30.8.	O
Blood	O
cultures	O
were	O
+ve	O
for	O
MRSA	O
___	O
bottles).	O
ID	O
was	O
consulted.	O
He	O
was	O
started	O
on	O
vancomycin	O
1g	O
q12h.	O
No	O
port	O
of	O
entry	O
could	O
be	O
identified	O
on	O
examination.	O
The	O
patient	O
complained	O
of	O
bilateral	O
___	O
pain,	O
so	O
ABD/PLV	O
CT	O
was	O
obtained	O
to	O
r/o	O
psoas	O
abscess	O
that	O
showed	O
no	O
sign	O
of	O
collection,	O
but	O
showed	O
significant	O
atelectasis	O
at	O
the	O
lung	O
bases	O
(may	O
be	O
related	O
to	O
massive	O
kidneys),	O
extensive	O
PCKD,	O
large	O
rounded	O
stool	O
in	O
the	O
distal	O
rectum	O
with	O
developing	O
stercoral	O
colitis.	O
Given	O
patient's	O
systolic	O
murmur	O
(baseline	O
but	O
cannot	O
confirm	O
if	O
unchanged),	O
TTE	O
was	O
obtained	O
that	O
did	O
not	O
show	O
any	O
valvular	O
vegetations.	O
A	O
chest	O
CTA	O
was	O
then	O
done	O
given	O
the	O
concern	O
for	O
infection	O
of	O
the	O
aortic	O
graft	O
that	O
showed	O
multiple	O
small	O
fluid	O
collections	O
measuring	O
up	O
to	O
1.5	O
x	O
1.0	O
cm	O
and	O
inflammatory	O
changes	O
are	O
adjacent	O
to	O
the	O
thoracic	O
ascending	O
aorta	O
and	O
endovascular	O
graft	O
and	O
raise	O
concern	O
for	O
graft	O
infection	O
with	O
small	O
abscesses.	O
Because	O
of	O
the	O
proximity	O
of	O
the	O
abscesses	O
and	O
the	O
high	O
suspicion	O
of	O
endocarditis,	O
a	O
TEE	O
was	O
ordered	O
to	O
evaluate	O
the	O
aortic	O
valves,	O
but	O
the	O
patient	O
was	O
unable	O
to	O
tolerate	O
the	O
procedure.	O
Cardiac	O
surgery	O
was	O
consulted	O
following	O
ID	O
recs	O
to	O
replace	O
graft.	O
Patient	O
was	O
not	O
deemed	O
to	O
be	O
a	O
surgical	O
candidate,	O
and	O
___	O
recommended	O
medical	O
management	O
with	O
follow-up	O
imaging	O
and	O
re-evaluation	O
after	O
full	O
course	O
of	O
IV	O
antibiotics.	O
Patient	O
became	O
culture	O
negative	O
on	O
___.	O
His	O
course	O
was	O
complicated	O
by	O
___	O
___	O
IV	O
contrast	O
vs.	O
glomerulonephritis.	O
Throughout	O
his	O
stay,	O
the	O
patient	O
required	O
constant	O
adjustment	O
of	O
his	O
vancomycin	O
dosing	O
with	O
daily	O
vancomycin	O
levels	O
because	O
of	O
his	O
rapidly	O
changing	O
renal	O
function.	O
ID	O
recommended	O
a	O
6-week	O
course	O
of	O
antibiotics	O
from	O
the	O
day	O
of	O
first	O
negative	O
culture.	O
Patient	O
had	O
a	O
PICC	O
line	O
place	O
on	O
___.	O
At	O
discharge,	O
the	O
patient's	O
Cr	O
had	O
settled	O
at	O
2.5-2.7,	O
and	O
per	O
pharmacy	O
recs,	O
patient	O
was	O
discharged	O
on	O
vancomycin	O
500mg	O
IV	O
q72h.	O
Patient	O
d/ced	O
with	O
OPAT	O
follow-up	O
with	O
weekly	O
vancomycin	O
levels,	O
CBC,	O
BUN,	O
and	O
Cr,	O
and	O
plan	O
to	O
re-adjust	O
vancomycin	O
dosing	O
as	O
needed.	O
Final	O
vanc	O
level	O
prior	O
to	O
discharge	O
was	O
20.0.	O
#	O
Acute	O
Kidney	O
Injury:	O
The	O
___	O
hospital	O
course	O
was	O
complicated	O
by	O
acute	O
kidney	O
injury.	O
He	O
had	O
an	O
increase	O
in	O
serum	O
creatinine	O
on	O
___	O
to	O
1.3	O
up	O
from	O
1.1	O
that	O
continued	O
to	O
uptrend	O
reaching	O
a	O
peak	O
of	O
2.8	O
on	O
___.	O
Patient	O
did	O
not	O
responded	O
to	O
fluid	O
boluses	O
and	O
became	O
oliguric	O
(200-300cc/24h).	O
Nephrology	O
was	O
consulted	O
and	O
suggested	O
following	O
creatinine	O
without	O
intervention	O
for	O
now.	O
The	O
___	O
was	O
presumed	O
to	O
be	O
related	O
to	O
either	O
IV	O
contrast	O
following	O
CTA	O
with	O
subsequent	O
ATN	O
or	O
glomerulonephritis	O
secondary	O
to	O
the	O
MRSA	O
bacteremia.	O
Acute	O
interstitial	O
nephritis	O
secondary	O
to	O
vancomycin	O
was	O
unlikely	O
given	O
lack	O
of	O
urine/serum	O
eosinophilia.	O
If	O
glomerulonephritis,	O
the	O
patient	O
would	O
have	O
benefited	O
from	O
steroids,	O
but	O
held	O
off	O
given	O
concurrent	O
infection.	O
Nephro	O
did	O
not	O
see	O
any	O
current	O
need	O
for	O
hemodialysis.	O
Patient	O
was	O
also	O
in	O
fluid	O
overload	O
that	O
worsened	O
following	O
his	O
___.	O
Patient	O
was	O
diuresed	O
the	O
last	O
2	O
days	O
prior	O
to	O
discharge	O
with	O
a	O
significant	O
decrease	O
in	O
his	O
___.	O
Patient's	O
creatinine	O
had	O
leveled	O
off	O
prior	O
to	O
discharge	O
and	O
began	O
decreasing	O
with	O
a	O
creatinine	O
on	O
___	O
of	O
2.5.	O
His	O
last	O
day	O
prior	O
to	O
discharge,	O
the	O
patient's	O
urine	O
output	O
increased	O
with	O
diuresis	O
(60	O
mg	O
of	O
furosemide	O
+	O
60	O
mg	O
torsemide)	O
to	O
950cc/24h.	O
He	O
was	O
d/ced	O
on	O
torsemide	O
60mg	O
PO	O
daily,	O
and	O
sodium	O
bicarbonate	O
650	O
mg	O
PO	O
BID	O
with	O
plan	O
for	O
follow-up	O
labs	O
within	O
___	O
days.	O
#	O
Anemia:	O
Chronic	O
anemia	O
(since	O
___	O
with	O
baseline	O
hct	O
___,	O
Hgb	O
downtrended	O
to	O
(7.0	O
on	O
___.	O
Patient	O
has	O
no	O
signs	O
or	O
symptoms	O
of	O
active	O
bleeding.	O
He	O
is	O
hemodynamically	O
stable.	O
Likely	O
anemia	O
of	O
chronic	O
disease/renal	O
insufficiency.	O
Given	O
the	O
plan	O
for	O
d/c	O
on	O
___,	O
patient	O
received	O
1U	O
of	O
PRBCs	O
with	O
60	O
mg	O
IV	O
Lasix,	O
with	O
an	O
appropriate	O
increase	O
in	O
Hgb	O
to	O
9.1	O
following	O
the	O
transfusion.	O
#	O
Constipation:	B-Constipation
Patient	O
with	O
known	O
chronic	O
constipation,	B-Constipation
had	O
CT	O
abdomen/pelvis	O
on	O
admission	O
that	O
showed	O
large	O
7.2	O
cm	O
stool	O
ball	O
in	O
the	O
distal	O
colon.	O
Patient	O
improved	O
and	O
was	O
stooling	O
regularly	O
following	O
aggressive	O
bowel	O
regimen.	O
Started	O
reporting	O
loose/watery	O
stools	O
on	O
___.	O
C.diff	O
screen	O
negative.	O
Patient	O
switched	O
to	O
PRN	O
laxatives	O
and	O
diarrhea	O
resolved.	O
****TRANSITIONAL	O
ISSUES****	O
#	O
OPAT	O
Instructions:	O
***Next	O
dose	O
of	O
vancomycin	O
due	O
on	O
___	O
(last	O
received	O
in	O
the	O
hospital	O
was	O
___	O
OPAT	O
Antimicrobial	O
Regimen	O
and	O
Projected	O
Duration:	O
Agent	O
&	O
Dose:	O
Vancomycin	O
1000mg	O
IV	O
Q	O
72	O
hours	O
(Final	O
dose	O
to	O
be	O
determined	O
based	O
on	O
adjustments	O
with	O
his	O
raising	O
creatinine)	O
Start	O
Date:	O
___	O
Projected	O
End	O
Date:	O
___	O
then	O
to	O
go	O
on	O
long	O
term	O
suppressive	O
PO	O
Bactrim	O
given	O
retained	O
hardware	O
ALL	O
LAB	O
RESULTS	O
SHOULD	O
BE	O
SENT	O
TO:	O
ATTN:	O
___	O
CLINIC	O
-	O
FAX:	O
___	O
VANCOMYCIN:	O
WEEKLY:	O
CBC	O
with	O
differential,	O
BUN,	O
Cr,	O
Vancomycin	O
trough	O
(30	O
min	O
prior	O
to	O
the	O
dose-	O
Goal	O
___,	O
ESR/CRP	O
All	O
questions	O
regarding	O
outpatient	O
parenteral	O
antibiotics	O
after	O
discharge	O
should	O
be	O
directed	O
to	O
the	O
___	O
R.N.s	O
at	O
___	O
or	O
to	O
the	O
on-call	O
ID	O
fellow	O
when	O
the	O
clinic	O
is	O
closed.	O
#	O
Patient	O
to	O
be	O
discharged	O
on	O
6	O
weeks	O
of	O
vancomycin	O
500mg	O
IV	O
q72h	O
with	O
projected	O
end	O
date	O
___.	O
Given	O
improving	O
renal	O
function,	O
will	O
require	O
follow-up	O
of	O
vancomycin	O
levels	O
and	O
adjustment.	O
Please	O
see	O
OPAT	O
instructions	O
above.	O
#	O
Patient	O
with	O
elevated	O
creatinine	O
likely	O
due	O
to	O
contrast	O
induced	O
___	O
vs.	O
glomerulonephritis.	O
Will	O
follow-up	O
with	O
Nephrology,	O
Dr.	O
___	O
on	O
___	O
for	O
further	O
management.	O
No	O
acute	O
requirement	O
for	O
hemodialysis.	O
#	O
Check	O
CMP	O
at	O
appointment	O
with	O
Dr.	O
___	O
on	O
___	O
#	O
Patient	O
remains	O
hypervolemic,	O
may	O
require	O
additional	O
diuresis	O
given	O
his	O
current	O
renal	O
function.	O
#	O
Stopped	O
home	O
losartan	O
given	O
___.	O
BP	O
well	O
controlled	O
in	O
the	O
hospital.	O
Continue	O
to	O
monitor	O
and	O
consider	O
initiation	O
of	O
other	O
anti-hypertensive	O
agents	O
if	O
needed	O
versus	O
resumption	O
of	O
home	O
losartan	O
pending	O
improvement	O
in	O
renal	O
function.	O
#	O
Changed	O
simvastatin	O
to	O
atorvastatin	O
80mg	O
for	O
hyperlipidemia	O
#	O
Started	O
metoprolol	O
25mg	O
XL	O
given	O
concern	O
for	O
underlying	O
CAD	O
given	O
episode	O
of	O
LBBB	O
which	O
had	O
resolved	O
by	O
time	O
of	O
discharge	O
#	O
Started	O
sodium	O
bicarb	O
650mg	O
TID	O
per	O
renal	O
recommendation	O
given	O
___	O
#	O
Code	O
Status:	O
Full	O
Code	O
#	O
Contact:	O
___	O
(companion):	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
2.	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
3.	O
Simvastatin	O
20	O
mg	O
PO	O
QPM	O
4.	O
Acetaminophen	O
500	O
mg	O
PO	O
TID:PRN	O
neck	O
pain	O
5.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
6.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
7.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
8.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
9.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
10.	O
Benefiber	O
Clear	O
SF	O
(dextrin)	O
(wheat	O
dextrin)	O
3	O
gram/3.5	O
gram	O
oral	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
500	O
mg	O
PO	O
TID:PRN	O
neck	O
pain	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
4.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
5.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
6.	O
Benefiber	O
Clear	O
SF	O
(dextrin)	O
(wheat	O
dextrin)	O
3	O
gram/3.5	O
gram	O
oral	O
DAILY	O
7.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
8.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
9.	O
Sodium	O
Bicarbonate	O
650	O
mg	O
PO	O
BID	O
10.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
11.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
12.	O
Outpatient	O
Lab	O
Work	O
ICD	O
10	O
Code	O
___	O
Please	O
check	O
weekly	O
CBC	O
with	O
differential,	O
BUN,	O
Cr,	O
Vancomycin	O
trough	O
(30	O
min	O
prior	O
to	O
the	O
dose-	O
Goal	O
___,	O
ESR	O
and	O
CRP	O
and	O
fax	O
to	O
___	O
CLINIC	O
-	O
FAX:	O
___	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSIS	O
MRSA	O
Septicemia	O
SECONDARY	O
DIAGNOSIS	O
Acute	O
on	O
Chronic	O
Kidney	O
Injury	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
___	O
because	O
you	O
were	O
feeling	O
unwell	O
and	O
we	O
discovered	O
bacteria	O
in	O
your	O
bloodstream	O
called	O
methicillin	O
resistant	O
staphylococcus	O
aureus	O
or	O
MRSA.	O
To	O
identify	O
the	O
source	O
of	O
this	O
bacteria,	O
we	O
did	O
a	O
scan	O
of	O
your	O
chest	O
that	O
showed	O
abscesses	O
around	O
the	O
graft	O
that	O
was	O
used	O
to	O
fix	O
the	O
main	O
blood	O
vessel	O
of	O
your	O
heart.	O
We	O
started	O
you	O
on	O
an	O
intravenous	O
antibiotic	O
called	O
vancomycin.	O
After	O
we	O
started	O
you	O
on	O
this	O
antibiotic	O
your	O
blood	O
was	O
cleared	O
of	O
this	O
bacteria.	O
You	O
will	O
need	O
to	O
take	O
this	O
antibiotic	O
for	O
at	O
least	O
6	O
weeks,	O
after	O
which	O
you	O
may	O
have	O
to	O
take	O
a	O
prolonged,	O
or	O
possibly	O
lifelong	O
course	O
of	O
oral	O
antibiotics	O
to	O
suppress	O
any	O
bacteria	O
that	O
is	O
left.	O
During	O
your	O
hospitalization,	O
your	O
kidney	O
function	O
worsened.	O
This	O
may	O
have	O
been	O
due	O
to	O
the	O
existing	O
infection	O
or	O
due	O
to	O
the	O
dye	O
that	O
your	O
received	O
for	O
your	O
scan.	O
We	O
have	O
been	O
monitoring	O
your	O
kidney	O
function	O
and	O
it	O
has	O
stabilized,	O
but	O
is	O
not	O
back	O
to	O
what	O
it	O
was	O
before	O
you	O
came	O
to	O
the	O
hospital.	O
You	O
will	O
need	O
to	O
follow-up	O
with	O
a	O
kidney	O
specialist	O
after	O
your	O
discharge	O
to	O
make	O
sure	O
your	O
kidney	O
function	O
has	O
not	O
worsened	O
and	O
that	O
you	O
do	O
not	O
need	O
new	O
medications	O
to	O
treat	O
your	O
kidney	O
problems.	O
We	O
wish	O
you	O
a	O
speedy	O
recovery,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

